Loading clinical trials...
Loading clinical trials...
A Multicentre, Cohort Study to Assess the Impact on SYMptom Burden and Patient Health-related Quality of Life of Afatinib Treatment in Advanced Non-small Cell Lung Cancer in a Real World Setting in Greece.
Conditions
Interventions
afatinib
Locations
7
Greece
University General Hospital of Evros
Alexandroupoli, Greece
Chest Hospital of Athens "Sotiria"
Athens, Greece
"Attikon" University General Hospital of Attica
Haidari, Greece
University General Hospital of Heraklion
Heraklion, Greece
Bioclinic Thessaloniki
Thessaloniki, Greece
Interbalkan Medical Center of Thessaloniki
Thessaloniki, Greece
Start Date
February 16, 2016
Primary Completion Date
February 17, 2021
Completion Date
February 17, 2021
Last Updated
April 27, 2022
NCT06855771
NCT06758401
NCT06120140
NCT06667908
NCT04165798
NCT06875310
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions